Mediastinal Gray-Zone Lymphoma — Trials

Mediastinal Gray-Zone Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: David Bond, MD
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–2 of 2 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03749018	Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma	active not recruiting	Phase 2	30	David Bond, MDOTHER	1	Feb 6, 2026	clinicaltrials
NCT03037177	Mediastinal Grey Zone Lymphoma From the LYSA	completed	—	99	Hospices Civils de LyonOTHER	1	Jan 31, 2017	clinicaltrials